How do you approach contraception counseling with transgender patients taking gender affirming hormone therapy prior to starting teratogenic medications?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

How do you decide when to use acid-suppressive medications for GI prophylaxis when patients are on prolonged corticosteroid therapy?

In patients with rheumatologic disease, which specific conditions are most strongly associated with mitral valve abnormalities (ex. Libman–Sacks endocarditis, valvulitis, or mitral regurgitation), and how does this influence your approach to screening, monitoring, or treatment?

When do you consider genetic testing for autoinflammatory diseases in patients with recurrent pericarditis and fever, particularly when symptoms are highly responsive to IL-1 blockade?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.